BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21530682)

  • 1. Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice.
    Huyan XH; Lin YP; Gao T; Chen RY; Fan YM
    Int Immunopharmacol; 2011 Sep; 11(9):1293-7. PubMed ID: 21530682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effect of oral and intravenous cyclophosphamide treatment on phenotypes of human peripheral blood lymphocytes.
    Lacki JK; Mackiewicz SH; Wiktorowicz KE
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):291-4. PubMed ID: 7487369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of immunosuppression induced by different doses of cyclophosphamide in normal mice].
    Qi L; Song Y; Wang W; Cui W; Zhang X; Liu Z; Sun N; Li N
    Wei Sheng Yan Jiu; 2010 May; 39(3):313-5, 325. PubMed ID: 20568461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes acceleration by cyclophosphamide in the non-obese diabetic mouse is associated with differentiation of immunosuppressive monocytes into immunostimulatory cells.
    Caquard M; Ferret-Bernard S; Haurogné K; Ouary M; Allard M; Jégou D; Bach JM; Lieubeau B
    Immunol Lett; 2010 Apr; 129(2):85-93. PubMed ID: 20144655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
    Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; Müller W
    Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AC II, an herbal formulation in cyclophosphamide-induced immunosuppression in BALB/c mice--Implication in HIV treatment.
    Tharakan ST; Kuttan G; Kuttan R; Kesavan M; Austin S; Rajagopalan K
    Immunol Invest; 2007; 36(2):147-57. PubMed ID: 17365016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of age and gender on gingival tissue and peripheral blood T-lymphocyte subsets: a study in mice.
    Demir T; Canakci V; Erdem F; Atasever M; Kara C; Canakci CF
    Immunol Invest; 2008; 37(2):171-82. PubMed ID: 18300042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on inhibitory effect of combined administration of bear bile powder and cyclophosphamide on colorectal cancer liver metastasis by regulating tumor microenvironment].
    Cui W; Liu S; Yang M; Zhang T; Cai L; Qiu SL; Zheng J; Miao YJ; Zhao LM; Du J
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1036-40. PubMed ID: 23847953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes and significance of peripheral blood platelet count in tumor shrinkage induced by a low dose of CTX in T739 mice].
    Li ML; Jia YJ; Jiang MN; Shu XH; Li CG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):567-9. PubMed ID: 18538085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation.
    Yang J; Ahn C; Jung HK; Kim EK; Kim JY; Kim YS; Han JS; Kim S; Lee JS
    Transpl Immunol; 2003; 11(2):197-206. PubMed ID: 12799204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen.
    Yao G; Liang J; Han X; Hou Y
    Int Immunopharmacol; 2003 Dec; 3(13-14):1853-60. PubMed ID: 14636834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
    Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
    Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.